Abstract

ObjectiveTo evaluate the dynamics of the oral microbiome and associated patient outcomes following treatment of head and neck squamous cell carcinoma (HNSCC).Materials and MethodsThis was a prospective cohort study at a tertiary academic center in Hong Kong SAR of patients with head and neck squamous cell carcinoma evaluating the oral microbiome in pre- and postsurgery oral rinses (at 1, 3, and 6 months) with 16S rRNA gene V3–V4 amplicon sequencing.ResultsIn total, 76 HNSCC patients were evaluated. There was a significantly depressed alpha diversities of oral microbial communities observed in HNSCC oral rinse samples within the first 6 months post-surgery when compared to presurgery or healthy controls. Distant clustering between pre- and postsurgery was also observed (p < 0.022). Following treatment, eight oral bacterial genera showed a trend towards the restoration in the relative abundances that approximate healthy persons. In evaluating patient outcomes, the decreased relative abundance of three periodontal bacteria (Capnocytophaga, Prevotella 7, and Leptotrichia) and the increased relative abundance of two commensal bacteria (Streptococcus and Rothia) at 6 months postsurgery compared to presurgery showed a better 3-year disease-specific survival (a cutoff of Kaplan–Meier survival curve test p < 0.3 at 36 months). In particular, the postsurgery restoration of Prevotella 7 was statistically significant in the surveyed patients (survival rate of 84% vs. 56% at 36 months, p = 0.0065).ConclusionsOral microbiome dysbiosis associated with HNSCC is dynamic. These dynamics of the oral microbiome postsurgery are also associated with patient treatment and outcomes and may serve as potential biomarkers for patient management in HNSCC.

Highlights

  • Disease surveillance is a challenging yet important aspect of care in head and neck squamous cell carcinoma (HNSCC)

  • In nasopharyngeal carcinoma (NPC), Epstein–Barr virus (EBV) DNA in plasma has been shown to be useful in the diagnosis, prognosis, and surveillance of NPC [4,5,6]

  • Human papillomavirus (HPV) DNA in plasma or oral rinses have been shown to be useful in the diagnosis and surveillance of human papillomavirus (HPV)-related oropharyngeal carcinomas [7, 8]

Read more

Summary

Introduction

Disease surveillance is a challenging yet important aspect of care in head and neck squamous cell carcinoma (HNSCC). The goal of surveillance is early detection, and yet it has been reported that 39% of recurrences are asymptomatic, thereby delaying diagnosis and potentially jeopardizing the possibility of salvage therapy with curative intent [1]. In nasopharyngeal carcinoma (NPC), Epstein–Barr virus (EBV) DNA in plasma has been shown to be useful in the diagnosis, prognosis, and surveillance of NPC [4,5,6]. Human papillomavirus (HPV) DNA in plasma or oral rinses have been shown to be useful in the diagnosis and surveillance of HPV-related oropharyngeal carcinomas [7, 8]. Somatic mutations of tumor DNA detected in saliva or plasma have been shown to be useful in the detection of HNSCC and potentially useful in disease surveillance [8]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call